View Agent
| Agent Info | |
| Agent: | ceritinib |
| Synonyms: | LDK378 |
| Drug Status For Certain Diseases: | Metastatic ALK-positive metastatic NSCLC unresponsive or intolerant to crizotinib(approved) |
| Classification: | 2nd-generation,oral,small-molecule, ATP-competitive, tyrosine kinase inhibitor of ALK |
| Target: | ALK |
| KEGG Pathway: | MAPK pathway PI3K-AKT pathway JAK-STAT pathway |
| Wiki Pathway: | NA |